Hello
I am a 56 yr old female bladder cancer patient. I was treated in 2021 for TCC pTa G1, with TURBT and a single post-op instillation of Mitomycin C. I have fortunately since been clear but am aware of the high reoccurrence rate of this cancer. Due to blood tests in connection with a minor health issue unconnected to my cancer, I am aware that I have had for several years (possibly longer, low lymphocytes (recently 0.9 - 1.1) and a NLR of 2 - 3.
I am aware of recent research in peer reviewed medical journals that concludes that a NLR in this range is a statistical indicator of poorer prognosis in cancer patients and yet my doctor seems unconcerned and although the hospital consultant who ordered some of the most recent blood tests, noted my results and suggested to my doctor she may consider referring to me to haematology, she doesn’t feel this is warranted.
I wanted to ask if NLR is recognised as a relevant indicator for disease (in my case recurrence) in cancer patients and whether, I should be worried. As my cancer was originally diagnosed by chance (scan for unrelated symptoms) and I have never had any of the recognised symptoms associated with it, I have ongoing anxiety about how I will know if it returns, at least until it has progressed as I believe I will not continue to be offered routine cystoscopies.
Thank you for your time.
Blue.